S2k Leitlinie Autoimmune Lebererkrankungen

Standard

S2k Leitlinie Autoimmune Lebererkrankungen. / Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).

In: Z GASTROENTEROL, Vol. 55, No. 11, 11.2017, p. 1135-1226.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) 2017, 'S2k Leitlinie Autoimmune Lebererkrankungen', Z GASTROENTEROL, vol. 55, no. 11, pp. 1135-1226. https://doi.org/10.1055/s-0043-120199

APA

Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (2017). S2k Leitlinie Autoimmune Lebererkrankungen. Z GASTROENTEROL, 55(11), 1135-1226. https://doi.org/10.1055/s-0043-120199

Vancouver

Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). S2k Leitlinie Autoimmune Lebererkrankungen. Z GASTROENTEROL. 2017 Nov;55(11):1135-1226. https://doi.org/10.1055/s-0043-120199

Bibtex

@article{e899ad31246a4e01bd12782da76a0c6b,
title = "S2k Leitlinie Autoimmune Lebererkrankungen",
abstract = "The guideline was created under the leadership of the DGVS and with participation of neighbouring scientific societies and is intended as a practical aid for the diagnosis and therapy of autoimmune liver diseases. The aim is to represent the current state of science, promote the recognition of the disease and improve the treatment of patients.",
keywords = "English Abstract, Journal Article",
author = "{Deutsche Gesellschaft f{\"u}r Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)}",
note = "{\textcopyright} Georg Thieme Verlag KG Stuttgart · New York.",
year = "2017",
month = nov,
doi = "10.1055/s-0043-120199",
language = "Deutsch",
volume = "55",
pages = "1135--1226",
journal = "Z GASTROENTEROL",
issn = "0044-2771",
publisher = "Karl Demeter Verlag GmbH",
number = "11",

}

RIS

TY - JOUR

T1 - S2k Leitlinie Autoimmune Lebererkrankungen

AU - Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

N1 - © Georg Thieme Verlag KG Stuttgart · New York.

PY - 2017/11

Y1 - 2017/11

N2 - The guideline was created under the leadership of the DGVS and with participation of neighbouring scientific societies and is intended as a practical aid for the diagnosis and therapy of autoimmune liver diseases. The aim is to represent the current state of science, promote the recognition of the disease and improve the treatment of patients.

AB - The guideline was created under the leadership of the DGVS and with participation of neighbouring scientific societies and is intended as a practical aid for the diagnosis and therapy of autoimmune liver diseases. The aim is to represent the current state of science, promote the recognition of the disease and improve the treatment of patients.

KW - English Abstract

KW - Journal Article

U2 - 10.1055/s-0043-120199

DO - 10.1055/s-0043-120199

M3 - SCORING: Zeitschriftenaufsatz

C2 - 29141269

VL - 55

SP - 1135

EP - 1226

JO - Z GASTROENTEROL

JF - Z GASTROENTEROL

SN - 0044-2771

IS - 11

ER -